{"cdcTestId":"2019-0002","testcaseName":"Zoster: Dose #2 (Shingrix) administered at 4 weeks - 4 days after dose #1","vaccineGroup":"ZOSTER","evaluationTestType":"All Valid: Forecast Test","forecastTestType":"Recommended based on minimum interval from invalid dose","assessmentDate":"2022-10-19T00:00:00","patient":{"dob":"1972-09-21T00:00:00","gender":"M"},"evaluation":{"seriesStatus":"Complete","administeredDoses":[{"dateAdministered":"2022-09-21T00:00:00","vaccineName":"zoster recombinant","cvx":"187","mvx":"","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-15T00:00:00","vaccineName":"zoster recombinant","cvx":"187","mvx":"","evaluationStatus":"Valid","evaluationReason":null}]},"forecast":{"forecastNum":"-","earliestDate":"0001-01-01T00:00:00","recommendedDate":"0001-01-01T00:00:00","pastDueDate":"0001-01-01T00:00:00"},"doses":[{"dateAdministered":"2022-09-21T00:00:00","vaccineName":"zoster recombinant","cvx":"187","mvx":"","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-15T00:00:00","vaccineName":"zoster recombinant","cvx":"187","mvx":"","evaluationStatus":"Valid","evaluationReason":null}],"dateAdded":"2018-03-27T20:00:00","dateUpdated":"2020-06-02T07:09:04.314","generalDescription":"This test case describes that when a patient is administered the second dose of Shingrix vaccine at 4 weeks - 4 day, that the dose is considered to be valid.","changedInVersion":"4.0","reasonForChange":""}